Georges Gemayel - 15 Nov 2021 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Role
Executive Chair of the Board of Directors, Director
Signature
/s/ Brian Piekos, attorney-in-fact
Issuer symbol
IRON
Transactions as of
15 Nov 2021
Net transactions value
$0
Form type
4
Filing time
16 Nov 2021, 06:56:41 UTC
Next filing
05 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRON Stock Option (Right to Buy) Award $0 +23,514 $0.000000 23,514 15 Nov 2021 Common Stock 23,514 $3.58 Direct F1
transaction IRON Stock Option (Right to Buy) Award $0 +17,245 $0.000000 17,245 15 Nov 2021 Common Stock 17,245 $3.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the option shall vest on August 5, 2022 so long as the Optionee continues to have a Service Relationship with the Company on such date.
F2 100% of the option shall vest on the earlier of (a) the one-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date.

Remarks:

Executive Chair of the Board of Directors